Ozempic and Wegovy contain semaglutide, but they are distinct FDA-approved products with different indications, presentations, dose instructions, storage rules, and missed-dose directions. Same active ingredient does not make them interchangeable.
Use the current Ozempic prescribing information and Wegovy prescribing information for the complete approved indications and instructions. Both labels have changed over time, so an older comparison may omit current uses or presentations.
Label Differences at a Glance
| Question | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Indications | Type 2 diabetes and specified risk-reduction uses in the populations stated in its current label | Indications differ between Wegovy injection and Wegovy tablets; see the current label |
| Presentations | Current label includes more than one injection presentation | Current label includes injection presentations and tablets |
| Dosing | Product- and presentation-specific Ozempic schedule | Product- and presentation-specific Wegovy schedule |
| Missed dose | Five-day rule for Ozempic | Different instructions by Wegovy formulation and number of missed doses |
| Storage | Presentation-specific | Presentation-specific |
This table is intentionally high level. The detailed label controls, including population-specific instructions and limitations of use.
Current Wegovy prescribing information gives Wegovy injection indications for cardiovascular-risk reduction in defined adults, weight reduction in defined adults and pediatric patients age 12 years and older, and treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced fibrosis consistent with stages F2 to F3 in adults. The MASH indication is approved under accelerated approval based on improvement of MASH and fibrosis; continued approval may depend on confirmation of clinical benefit. Wegovy tablets have adult cardiovascular-risk-reduction and weight-reduction indications in the defined populations, not the injection label's pediatric weight or MASH indications.
Same Molecule, Different Products
Semaglutide is a GLP-1 receptor agonist. The shared ingredient explains overlapping pharmacology and some overlapping adverse reactions, but the products were approved under different labels and clinical programs.
Do not infer that an Ozempic dose equals the same numbered Wegovy dose. The prescribed formulation, presentation, treatment indication, prior exposure, and tolerability all matter. A switch plan must come from the prescriber.
Current Presentations Matter
Older comparison articles often describe Ozempic only as a multi-dose pen and Wegovy only as a single-dose pen. The current labels include additional presentations. This changes device instructions, storage, and missed-dose guidance.
Before acting on instructions, identify:
- the brand name;
- injection or tablet formulation;
- the exact pen, syringe, or other presentation;
- dose strength;
- whether a multi-dose device has been used;
- the label revision packaged with the medication.
Never use one device's Instructions for Use to operate another.
Missed Doses Are Not the Same
The Ozempic label says a missed dose may be administered within five days; after that, it is skipped and the regular schedule resumes. Wegovy has formulation-specific missed-dose instructions. For injections, the next scheduled dose and whether multiple consecutive doses were missed matter. Tablets have their own directions.
That is why “they are both semaglutide” is not enough to answer a missed-dose question. Read the exact label or ask a pharmacist. Do not take an extra dose to reconcile two different sets of instructions.
Storage Is Presentation-Specific
Current Ozempic and Wegovy labels contain different storage subsections for their listed presentations. Do not apply a multi-dose pen's in-use window to a single-dose syringe or a single-dose product's room-temperature allowance to a FlexTouch pen.
If medication was left out, frozen, overheated, or stored for an uncertain time, record the details and contact the dispensing pharmacy. See the GLP-1 storage guide for a label-first checklist.
Switching Requires a Prescription Plan
A clinician may consider a switch because of the treated condition, coverage, availability, tolerability, or another factor. The labels do not provide a universal patient conversion between Ozempic and Wegovy.
Confirm the exact product, presentation, dose, first administration date, and what to do with any remaining supply. Do not match milligrams or continue an old schedule on your own.
Tracking Without Mixing the Products Up
Record the full brand and formulation rather than “semaglutide” alone. A useful entry includes dose, date, presentation, and any clinician instruction. That helps prevent an Ozempic storage or missed-dose rule from being applied to Wegovy, or vice versa.
OffGrid Dose can organize the medication and dose information you enter. It does not choose the correct product, convert doses, or replace the label. The app stores its working data on your iPhone, and OffGrid Dose has no account, company-operated cloud sync, or server-side health database. Depending on your Apple and device settings, an encrypted device backup may include app data.
Frequently Asked Questions
Are Ozempic and Wegovy the same?
They contain the same active ingredient but are different approved products. Use the exact label for the product and presentation dispensed.
Which is stronger?
“Stronger” is not a useful label comparison. The products have different indications and dose instructions, and suitability is individualized.
Can I switch at the same milligram dose?
Do not make that conversion yourself. The prescriber should provide the exact product, presentation, dose, and timing plan.
Are their missed-dose rules identical?
No. Follow the current formulation-specific label.
This article is for general educational purposes only and is not medical advice. Ozempic and Wegovy prescribing, switching, dosing, storage, and missed-dose decisions require the current label and qualified clinical guidance.
Related Articles
Track this with OffGrid Dose
Log every dose, rotate injection sites, and watch your weight trend in a private local working log.
Ozempic tracker →